These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 18756485

  • 1. Monitoring peripheral blood CD4+ adenosine triphosphate activity in a liver transplant cohort: insight into the interplay between hepatitis C virus infection and cellular immunity.
    Mendler M, Kwok H, Franco E, Baron P, Weissman J, Ojogho O.
    Liver Transpl; 2008 Sep; 14(9):1313-22. PubMed ID: 18756485
    [Abstract] [Full Text] [Related]

  • 2. Monitoring peripheral blood CD4+ adenosine triphosphate activity in recurrent hepatitis C and its correlation to fibrosis progression.
    Alkhouri N, Hanouneh IA, Lopez R, Zein NN.
    Liver Transpl; 2010 Feb; 16(2):155-62. PubMed ID: 20104483
    [Abstract] [Full Text] [Related]

  • 3. Measurement of CD4+ T-cell function in predicting allograft rejection and recurrent hepatitis C after liver transplantation.
    Hashimoto K, Miller C, Hirose K, Diago T, Aucejo F, Quintini C, Eghtesad B, Corey R, Yerian L, Lopez R, Zein N, Fung J.
    Clin Transplant; 2010 Feb; 24(5):701-8. PubMed ID: 20047619
    [Abstract] [Full Text] [Related]

  • 4. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): Posttransplantation outcome-Comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis.
    Aguilera V, Berenguer M, Rubín A, San-Juan F, Rayón JM, Prieto M, Mir J.
    Liver Transpl; 2009 Jan; 15(1):79-87. PubMed ID: 19109849
    [Abstract] [Full Text] [Related]

  • 5. Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection.
    Bhorade SM, Janata K, Vigneswaran WT, Alex CG, Garrity ER.
    J Heart Lung Transplant; 2008 Sep; 27(9):990-4. PubMed ID: 18765191
    [Abstract] [Full Text] [Related]

  • 6. Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation.
    Sreekumar R, Gonzalez-Koch A, Maor-Kendler Y, Batts K, Moreno-Luna L, Poterucha J, Burgart L, Wiesner R, Kremers W, Rosen C, Charlton MR.
    Hepatology; 2000 Nov; 32(5):1125-30. PubMed ID: 11050065
    [Abstract] [Full Text] [Related]

  • 7. Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection.
    Schirren CA, Jung M, Worzfeld T, Mamin M, Baretton GB, Gruener NH, Gerlach JT, Diepolder HM, Zachoval R, Pape GR.
    Liver Transpl; 2000 Mar; 6(2):222-8. PubMed ID: 10719024
    [Abstract] [Full Text] [Related]

  • 8. Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern?
    Berenguer M, Aguilera V, Prieto M, Carrasco D, Rayón M, San Juan F, Landaverde C, Mir J, Berenguer J.
    Liver Transpl; 2003 Nov; 9(11):1152-8. PubMed ID: 14586875
    [Abstract] [Full Text] [Related]

  • 9. A prospective randomized trial comparing tacrolimus and steroids with tacrolimus monotherapy in liver transplantation: the impact on recurrence of hepatitis C.
    Margarit C, Bilbao I, Castells L, Lopez I, Pou L, Allende E, Escartin A.
    Transpl Int; 2005 Dec; 18(12):1336-45. PubMed ID: 16297052
    [Abstract] [Full Text] [Related]

  • 10. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M, Fernandez JR, Suarez MJ, Gastaca M, Bustamante J, Pijoan JI, Montejo M, Valdivieso A, Ruiz P, Gonzalez J, Ortiz de Urbina J.
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [Abstract] [Full Text] [Related]

  • 11. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P, Senzolo M, Masier A, Prestele H, Jones R, Samuel D, Villamil F.
    Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
    [Abstract] [Full Text] [Related]

  • 12. Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts.
    Tao R, Ruppert K, Cruz RJ, Malik SM, Shaikh O, Ahmad J, DiMartini A, Humar A, Fontes PA, de Vera ME.
    Liver Transpl; 2010 Nov; 16(11):1288-95. PubMed ID: 21031544
    [Abstract] [Full Text] [Related]

  • 13. Hepatitis C virus-specific CD4+ T cell response after liver transplantation occurs early, is multispecific, compartmentalizes to the liver, and does not correlate with recurrent disease.
    Schirren CA, Jung MC, Worzfeld T, Mamin M, Baretton G, Gerlach JT, Gruener NH, Zachoval R, Houghton M, Rau HG, Pape GR.
    J Infect Dis; 2001 Apr 15; 183(8):1187-94. PubMed ID: 11262200
    [Abstract] [Full Text] [Related]

  • 14. Patterns of recurrent hepatitis C after liver transplantation in a recent cohort of patients.
    Khettry U, Huang WY, Simpson MA, Pomfret EA, Pomposelli JJ, Lewis WD, Jenkins RL, Gordon FD.
    Hum Pathol; 2007 Mar 15; 38(3):443-52. PubMed ID: 17188331
    [Abstract] [Full Text] [Related]

  • 15. Exploring the bidirectional interactions between human cytomegalovirus and hepatitis C virus replication after liver transplantation.
    Nebbia G, Mattes FM, Cholongitas E, Garcia-Diaz A, Samonakis DN, Burroughs AK, Emery VC.
    Liver Transpl; 2007 Jan 15; 13(1):130-5. PubMed ID: 17192909
    [Abstract] [Full Text] [Related]

  • 16. Recurrent hepatitis C virus disease after liver transplantation and concurrent biliary tract complications: poor outcome.
    Katz LH, Mor E, Brown M, Bar-Nathan N, Shaharabani E, Sulkes J, Pappo O, Tur-Kaspa R, Ben-Ari Z.
    Clin Transplant; 2006 Jan 15; 20(4):465-70. PubMed ID: 16842523
    [Abstract] [Full Text] [Related]

  • 17. Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus.
    Fiel MI, Agarwal K, Stanca C, Elhajj N, Kontorinis N, Thung SN, Schiano TD.
    Liver Transpl; 2008 Jun 15; 14(6):861-71. PubMed ID: 18508382
    [Abstract] [Full Text] [Related]

  • 18. A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation.
    Yilmaz N, Shiffman ML, Stravitz RT, Sterling RK, Luketic VA, Sanyal AJ, Mills AS, Contos MJ, Coterell A, Maluf D, Posner MP, Fisher RA.
    Liver Transpl; 2007 Jul 15; 13(7):975-83. PubMed ID: 17600360
    [Abstract] [Full Text] [Related]

  • 19. Hepatic venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrhosis.
    Samonakis DN, Cholongitas E, Thalheimer U, Kalambokis G, Quaglia A, Triantos CK, Mela M, Manousou P, Senzolo M, Dhillon AP, Patch D, Burroughs AK.
    Liver Transpl; 2007 Sep 15; 13(9):1305-11. PubMed ID: 17763383
    [Abstract] [Full Text] [Related]

  • 20. Reconstitution of hepatitis C virus-specific T-cellmediated immunity after liver transplantation.
    Weston SJ, Leistikow RL, Reddy KR, Torres M, Wertheimer AM, Lewinsohn DM, Chou S, Davey MP, Corless C, O'Farrelly C, Nelson DR, Rosen HR.
    Hepatology; 2005 Jan 15; 41(1):72-81. PubMed ID: 15619226
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.